How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comStudy of 177Lu-PSMA-0057 in Metastatic Prostate Cancer
Description:
The purpose of this study is to evaluate the effectiveness and safety of 177Lu-PSMA-0057 in metastatic prostate cancer.
Sponsor:
Nanjing First Hospital, Nanjing Medical University
Phase:
Early Phase 1
Contacts:
Feng Wang (Study Director)fengwangcn@hotmail.com
02552271491
Government Study Link:
NCT06050239 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience